Skip to main content
. 2020 Mar 30;61(6):E1–E35. doi: 10.1111/jsap.13125

Table 4.

An aspirational vaccination programme for LATAM practitioners

Type of vaccine Puppy or kitten vaccination Adult animal revaccination

Quality‐assured core MLV vaccines

For dogs including CDV, CAV and CPV2

For cats including FPV, FCV and FHV1

Start at 6 to 8 weeks of age then every 2 to 4 weeks until 16 weeks of age or older [EB1]

Core vaccination may be started earlier, but never earlier than 4 weeks of age with MLV products. For puppies a product containing high‐titre CDV and CPV2 may be used at 4 to 6 weeks (if available) before switching to trivalent core vaccine at 8 weeks or older [EB1]

A fourth vaccine should be given between 6 to 12 months of age OR 12 months after the third vaccine OR at 12 months of age [EB4]

Revaccination with core, quality‐assured MLV vaccines should be no more frequent than every 3 years [EB1]. Serology might be used to monitor protective immunity (for CDV, CAV, CPV2 and FPV) and to aid decision making on revaccination intervals [EB1]

The single exception to this may be cats at high risk of contracting upper respiratory virus, in which these components may be given annually [EB1]

Quality‐assured canine rabies vaccine for client‐owned pet dogs or cats (note this does not refer to mass vaccination campaigns)

According to manufacturer's recommendations; one dose from 12 weeks of age [EB1]

The VGG recommends that in high risk areas (i.e. NOT most areas of LATAM) a second dose may be given 2 to 4 weeks later

A second vaccine in non‐high‐risk areas should be given 12 months later or at 12 months of age

Quality‐assured canine rabies vaccines all carry a 3‐year licensed DOI in many countries outside of LATAM [EB1]

Non‐core vaccines

Examples for dogs: Leptospira, canine infectious respiratory disease complex (“kennel cough”) and Leishmania

Examples for cats: feline leukaemia virus or C. felis (vaccines against feline immunodeficiency virus and Bordetella [for cats] are not available in LATAM)

Give according to manufacturer's recommendations: generally two doses 2 to 4 weeks apart. Injectable non‐core vaccines and oral CIRDC vaccines are generally given from 8 weeks of age. Intranasal CIRDC vaccines may be given earlier (follow manufacturer's recommendations) [EB1] Non‐core vaccines are generally given annually unless the datasheet specifically recommends otherwise. FeLV vaccines may be given every 2 or years to adult cats (and some quality‐assured FeLV vaccines carry a licensed 2‐ or 3‐year DOI in markets outside of LATAM) [EB1]

Not recommended vaccines

These include vaccines against coronavirus (canine or feline), Giardia and Microsporum canis

The generic information in this table should be read in conjunction with the more detailed recommendations provided in the current WSAVA vaccination guidelines (Day et al. 2016). Vaccination according to WSAVA guidelines is possible only where available product ranges separate core from non‐core vaccine components. Note that these recommendations apply only to quality‐assured vaccines, most of which are produced by large, international companies.